Literature DB >> 2412822

Evaluation of 99mTc-dextran as a lymphoscintigraphic agent in rabbits.

M T Ercan, M Schneidereit, R Senekowitsch, H Kriegel.   

Abstract

Dextran (clinical grade, average mol. wt. 82,200) was labelled with 99mTc and the labelling efficiency was checked by paper and thin-layer chromatography and electrophoresis. The amount of free 99mTcO-4 was always less than 1%. The radiopharmaceutical was injected ID into the web space in hind legs of ten rabbits (200-600 microCi/0.05 ml). Scintigrams were taken at 10-min intervals up to 3 h in three rabbits. The injection site and the hind legs were massaged after injection in the other seven rabbits and scintigrams were taken at 10-min intervals up to 2 h. Blood samples were obtained at 5, 15, 30, 90 and 120 min in both groups. In addition a 180-min sample was also taken in the first group. At the end of the study the rabbits were killed and the popliteal lymph nodes and the organs were removed to be weighed and counted. Our results indicated a high concentration of radioactivity in the popliteal lymph nodes and massage at the injection site increased the average uptake of the popliteal lymph node from 1.12% +/- 0.77% to 4.28% +/- 1.57% at 3 and 2 h, respectively (P less than 0.001). In scintigrams the lymph channels and the nodes were very well visualised. The blood radioactivity levels were too low to present a background problem. With massage 30% of the injected dose was removed from the injection site in 2 h. We have shown that 99mTc-dextran is a good radiopharmaceutical for the visualisation of the lymph system and deserves further experimental and clinical studies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412822     DOI: 10.1007/bf00252139

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  11 in total

1.  Interstitial radiocolloid iliopelvic lymphoscintigraphy: technique, anatomy and clinical application.

Authors:  G N Ege; B J Cummings
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-11       Impact factor: 7.038

2.  Particle sizing and biokinetics of interstitial lymphoscintigraphic agents.

Authors:  L Bergqvist; S E Strand; B R Persson
Journal:  Semin Nucl Med       Date:  1983-01       Impact factor: 4.446

3.  Quantitative lymphoscintigraphy for detection of metastases to the internal mammary lymph nodes. Biokinetics of 99Tcm-sulphur colloid uptake and correlation with microscopy.

Authors:  K Aspegren; S E Strand; B R Persson
Journal:  Acta Radiol Oncol Radiat Phys Biol       Date:  1978

4.  Deposition of small 99mTc-labelled colloids in bone marrow and lymph nodes.

Authors:  K Nagai; Y Ito; N Otsuka; A Muranaka
Journal:  Eur J Nucl Med       Date:  1982

5.  Lymphoscintigraphy: a comparison of 99Tc(m) antimony sulphide colloid and 99Tc(m) stannous phytate.

Authors:  G N Ege; A Warbick
Journal:  Br J Radiol       Date:  1979-02       Impact factor: 3.039

6.  Technetium-99m sulfur-colloid cutaneous lymphoscintigraphy in the management of truncal melanoma.

Authors:  C M Meyer; M L Lecklitner; J R Logic; C E Balch; P Q Bessey; W N Tauxe
Journal:  Radiology       Date:  1979-04       Impact factor: 11.105

7.  A comparison of two technetium-99m-labeled radiopharmaceuticals for lymphoscintigraphy: concise communication.

Authors:  W D Kaplan; M A Davis; C M Rose
Journal:  J Nucl Med       Date:  1979-09       Impact factor: 10.057

8.  Tc-99m dextran: a new blood-pool-labeling agent for radionuclide angiocardiography.

Authors:  E Henze; G D Robinson; D E Kuhl; H R Schelbert
Journal:  J Nucl Med       Date:  1982-04       Impact factor: 10.057

9.  Lymphoscintigraphy with Tc-99m-labeled dextran.

Authors:  E Henze; H R Schelbert; J D Collins; A Najafi; J R Barrio; L R Bennett
Journal:  J Nucl Med       Date:  1982-10       Impact factor: 10.057

10.  Lymphoscintigraphy--techniques and applications in the management of breast carcinoma.

Authors:  G N Ege
Journal:  Semin Nucl Med       Date:  1983-01       Impact factor: 4.446

View more
  7 in total

1.  Hybrid 99mTc-magnetite tracer for dual modality sentinel lymph node mapping.

Authors:  Aidan Cousins; Chris Tsopelas; George Balalis; Sarah K Thompson; Dylan Bartholomeusz; A Bruce Wedding; Benjamin Thierry
Journal:  J Mater Sci Mater Med       Date:  2018-05-29       Impact factor: 3.896

2.  Scintigraphic method to quantify the passage from brain parenchyma to the deep cervical lymph nodes in rats.

Authors:  H Widner; B A Jönsson; L Hallstadius; K Wingårdh; S E Strand; B B Johansson
Journal:  Eur J Nucl Med       Date:  1987

3.  Quality control of 99mTc-labeled dextran for lymphoscintigraphy.

Authors:  K T Yang; S B Jong; C C Wu; J Y Chen; Y J Chen; L H Yang
Journal:  Eur J Nucl Med       Date:  1989

4.  Evaluation in vitro and in vivo of two labelling techniques of different 99mTc-dextrans for lymphoscintigraphy.

Authors:  K Wingårdh; S E Strand
Journal:  Eur J Nucl Med       Date:  1989

5.  Iliopelvic lymphoscintigraphy with 99mTc-dextran in malignant lymphoma.

Authors:  S Naldöken; M T Ercan; C F Bekdik
Journal:  Eur J Nucl Med       Date:  1990

6.  The in vitro characterization and biostability of 99mTc-dextran and its accumulation within the inflamed paws of adjuvant-induced arthritic rats.

Authors:  I W Kellaway; L Seale; P S Spencer
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

7.  Finding an optimal method for imaging lymphatic vessels of the upper limb.

Authors:  Susan O'Mahony; Sarah L Rose; Alison J Chilvers; James R Ballinger; Chandra K Solanki; Robert W Barber; Peter S Mortimer; Arnie D Purushotham; A Michael Peters
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.